Takeda India launches ‘For You, With You IBD’ app to support personalized care for people with IBD

New patient services initiative aims to empower more than a million IBD patients in India through tracking, education and daily support tools

0
82
New Delhi: Takeda Biopharmaceuticals India has launched ‘For You, With You IBD’ (FYWY IBD), a mobile application designed to support individuals having Inflammatory Bowel Disease (IBD).Takeda’s patient-centric strategy, the initiative is a digital health solution aimed at supporting everyday disease management and patient well-being.
India currently accounts for one of the world’s largest populations of people living with IBD. A 2023 Lancet study by the IBD Centre at the Asian Institute of Gastroenterology (AIG), Hyderabad, revealed a sharp rise in prevalence from 0.1% in 2006 to more than 5% by 2022, highlighting an urgent need for accessible patient support mechanisms.[1] Complementing this, the Global Burden of Disease 2019 study estimated 2,70,719 IBD cases in India, with an age-standardised prevalence rate of 20.34 per 100,000 more than double the 1,30,000 cases in 1990. While diagnoses of ulcerative colitis are increasing, Crohn’s disease is often underdiagnosed and is becoming a growing public health concern. IBD’s non-specific symptoms frequently lead to delayed diagnosis and treatment, reducing patients’ quality of life. Managing symptoms such as bowel urgency and ensuring quick access to toilets remain major challenges, as these significantly affect daily functioning and cause anxiety.
With IBD cases on the rise across India, Takeda’s ‘For You, With You IBD’ (FYWY IBD) app represents a pivotal step in addressing this growing challenge through innovative, care-driven, patient-centered technology. Co-created with inputs from patients and clinicians, and grounded in medical expertise, the app serves as a digital companion, empowering individuals to manage their IBD with greater ease, confidence, and inclusivity. By enabling users to track their health, gain deeper understanding into their condition, and stay connected to their care teams, FYWY transforms the patient experience. This intuitive platform not only addresses unmet needs but also builds a sense of control and community, delivering impactful, real-world support directly to patients’ fingertips.
Commenting on the launch, Annapurna Das, General Manager, Takeda Biopharmaceuticals India Pvt Ltd, said, “At Takeda, we are committed to building for India with empathy and a long-term vision. ‘For You, With You’ empowers people with IBD by addressing daily challenges with tools like the ePROM IBD Disk for symptom tracking and the IBD Smart for doctor-reviewed guidance on nutrition, self-care, and well-being. Co-created with clinicians and patients, this app delivers education, monitoring, and appointment support, enhancing patient confidence and outcomes through innovative care.”
A key feature, the Toilet Finder, uses GPS to help patients locate safe, clean and reliable washrooms across India and even across borders, enabling them to travel for work or leisure without anxiety. Another feature, the Appointment Scheduler, helps ensure patients never miss follow-ups with their doctors, nutritionists, psychologists or lab tests by allowing them to set reminders within the app. FYWY app is now live and available on iOs App Store and Android Playstore.